Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Hum Reprod 30 , 24112418, (2015)
Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management and chronic weight management
Lilly PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL MOUNJARO KwikPen 2.5 mg per dose (10 mg/2.4 mL [4.17 mg/mL]) NDC 0002-3466-11 Rx Only Mounjaro KwikPen (tirzepatide) injection 2.5 mg per dose 10 mg/2.4 mL (4.17 mg/mL) 1 Pen with 4 doses of 2.5 mg TURN THE DOSE KNOB ALL THE WAY UNTIL YOU SEE A
New clients receive a complimentary medical consultation and lab tests ($100 value), as well as monthly weigh-in visits
These drugs have been around for over a decade now, and we can go and look into the epidemiologic evidence and see: these are the people with diabetes who took these drugs, and these are people with diabetes who didnt
She began using the drug in 2024, after she finished breastfeeding her younger daughter
US$ 29.50
US$ 24.21
US$ 23.10
US$ 26.31
